Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

By Rothman A.L.   Kanesa-thasan N.   West K.   Janus J.   Saluzzo J.-F.   Ennis F.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4694-4699

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines

By Crowe J.E.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1423-1432

Elsevier

Access to resources Recommend Favorite

Clinical proof of principle for ChimeriVax&unknown;: recombinant live, attenuated vaccines against flavivirus infections

By Monath T.P.   McCarthy K.   Bedford P.   Johnson C.T.   Nichols R.   Yoksan S.   Marchesani R.   Knauber M.   Wells K.H.   Arroyo J.   Guirakhoo F.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1004-1018

Elsevier

Access to resources Recommend Favorite

Live attenuated vaccines against influenza; an historical review

By Wareing M.D.   Tannock G.A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3320-3330

Elsevier

Access to resources Recommend Favorite